Agilent Technologies Inc.
Agilent Reports Strong Q3 2025 Financial Results with Revenue Growth and EPS Increase
Summary
Agilent Technologies, Inc. reported a strong third quarter for fiscal year 2025, with total revenue of $1.74 billion, marking a 10.1% increase year-over-year and exceeding prior guidance. The company reported GAAP net income of $336 million, or $1.18 per share, and non-GAAP net income of $390 million, or $1.37 per share, both showing increases compared to the same period in 2024. Agilent also raised its full-year revenue outlook to a range of $6.91 billion to $6.93 billion, with non-GAAP EPS expected between $5.56 and $5.59.
Profitelligence Alerts
Get alerts for A
Be first to know when Agilent Technologies Inc. files with the SEC.
Filing Categories
Advertisement
About Agilent Technologies Inc.
Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.
Official SEC Documents
Advertisement